SBI Okasan Asset Management Co.Ltd.
Position in DNLI — Denali Therapeutics Inc.
CIK 1535128
TOKYO, M0
Position in DNLI
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$758,740
+$192,340 QoQ
Shares Held
29,500
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#140
of 290 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SBI Okasan Asset Management Co.Ltd. holds $25,087,909 across 27 Biotechnology names. DNLI ranks #15 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
26,300 | $2,143,713 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
9,900 | $1,854,072 | |
| 3 | ARGX |
Argenx SE
|
1,900 | $1,762,763 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
14,200 | $1,662,394 | |
| 5 | INSM |
INSMED Inc
|
14,700 | $1,567,314 | |
| 6 | VERA |
Vera Therapeutics, Inc.
|
26,200 | $1,124,242 | |
| 7 | CGON |
CG Oncology, Inc.
|
15,600 | $1,108,380 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
12,600 | $999,054 |
All Filings in DNLI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,740 | 29,500 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $566,400 | 29,500 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $297,180 | 18,000 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||